4 June 2024

Untangling complexity: A step-by-step guide to crafting optimal portfolios under the Matching Adjustment (2024 edition)

In our 2024 edition, we provide insight into the proposed MA reforms and the key areas in which this will impact insurers from an investment and reporting perspective.

The UK bulk annuity market is uniquely positioned within the UK Solvency II regulated market operating under the Matching Adjustment. This provides life insurers with the ability to invest in matching portfolios containing long dated spread assets without generating significant capital charges and with minimal volatility in their own funds. The MA is complex and our intention is to provide clarity and precision to the regulatory requirements which can be challenging to comprehend, especially for those new to the industry.

This paper provides a detailed overview of all the key topics that are relevant to managing the assets of Matching Adjustment portfolios with a particular focus on developing efficient MA portfolios through the global fixed income markets. This is particularly important in the context of the current levels of growth in the pension risk transfer market and the lack of diversification offered by UK fixed income.

Download the report

Sponsored by
Contact
Latest Stories
  • Elo backs €80m Finnish SaaS fund

    26 January 2026

    Vendep Capital's fund will target Nordic and Baltic SaaS founders at pre-seed to Series A stage

  • Aviva completes £4m buy-in with The Finnair Oyj Retirement Benefit Scheme

    26 January 2026

    Completed with Aviva's Clarity service

  • Just Group signs £105m refinancing deal with Arada London

    26 January 2026

    Leads £111m refinancing secured against three office properties in Hertfordshire and London

  • Danish pension insurer dumps US sovereigns

    26 January 2026

    Not because of Greenland tension, but for "weak public finances" in US

  • Canada Life AM provides £129m real estate loan

    26 January 2026

    Completes deal with Cortland on Manchester BTR development